Vimarsana
Biggest News Aggregation in the World

Page 26 - Breakthrough Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Today - Breaking & Trending Today

Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India - Vimarsana News

Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India

SAN DIEGO, May 22, 2023 /PRNewswire/ -- Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases,... | May 22, 2023

Locate Bio's LDGraft Granted FDA Breakthrough Device Designation - Vimarsana News

Locate Bio's LDGraft Granted FDA Breakthrough Device Designation

LDGraft is a next-generation bone graft substitute for spinal fusion, with uniquely encapsulated rhBMP-2 for controlled and extended-release Seeking to target significant and growing chronic low

Brain implant company Paradromics one step closer to FDA approval - Vimarsana News

Brain implant company Paradromics one step closer to FDA approval

Paradromics has received the Breakthrough Device designation from the FDA

Source: cnbc.com
Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update

Hypertension in Pacemaker Patients Global pivotal study evaluating the efficacy and safety of BackBeat CNT in adult patients with hypertension who are indicated for a pacemaker on track to start in... | May 12, 2023

Better Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates - Vimarsana News

Better Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

On track for an FDA decision mid-year Announced restructuring to extend cash runway Completed private placement financing Company to host conference call and webcast today at 8:30 a.m. ET ... | May 11, 2023